{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:10:23Z","timestamp":1788801023152,"version":"build-2803163510"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Innovation Program for Cultivation Project of Discipline Leaders in Anhui Province","award":["DTR2024029"],"award-info":[{"award-number":["DTR2024029"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-026-03817-w","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:04:40Z","timestamp":1784221480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glycosylation-related gene risk model and functional validation of OSTC and TUBA1C in lung adenocarcinoma"],"prefix":"10.1186","volume":"27","author":[{"given":"Xinyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengjie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofu","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengping","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqun","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"1","key":"3817_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3817_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"3817_CR3","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/s1470-2045(23)00444-8","volume":"24","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Vaccarella S, Morgan E, et al. Global variations in lung cancer incidence by histological subtype in 2020: a population-based study. Lancet Oncol. 2023;24(11):1206\u201318. https:\/\/doi.org\/10.1016\/s1470-2045(23)00444-8.","journal-title":"Lancet Oncol"},{"key":"3817_CR4","doi-asserted-by":"publisher","unstructured":"Smolarz B, \u0141ukasiewicz H, Samulak D, et al. Lung Cancer-Epidemiology, Pathogenesis, Treatment and Molecular Aspect (Review of Literature). Int J Mol Sci. 2025;26(5). https:\/\/doi.org\/10.3390\/ijms26052049.","DOI":"10.3390\/ijms26052049"},{"key":"3817_CR5","doi-asserted-by":"publisher","first-page":"115891","DOI":"10.1016\/j.biopha.2023.115891","volume":"169","author":"Y Li","year":"2023","unstructured":"Li Y, Yan B, He S. Advances and challenges in the treatment of lung cancer. Biomed Pharmacother. 2023;169:115891. https:\/\/doi.org\/10.1016\/j.biopha.2023.115891.","journal-title":"Biomed Pharmacother"},{"issue":"10454","key":"3817_CR6","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/s0140-6736(24)01029-8","volume":"404","author":"ML Meyer","year":"2024","unstructured":"Meyer ML, Fitzgerald BG, Paz-Ares L, et al. New promises and challenges in the treatment of advanced non-small-cell lung cancer. Lancet. 2024;404(10454):803\u201322. https:\/\/doi.org\/10.1016\/s0140-6736(24)01029-8.","journal-title":"Lancet"},{"issue":"6","key":"3817_CR7","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1200\/jco.21.01845","volume":"40","author":"A Passaro","year":"2022","unstructured":"Passaro A, Brahmer J, Antonia S, et al. Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies. J Clin Oncol. 2022;40(6):598\u2013610. https:\/\/doi.org\/10.1200\/jco.21.01845.","journal-title":"J Clin Oncol"},{"issue":"8","key":"3817_CR8","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","volume":"27","author":"M Wang","year":"2021","unstructured":"Wang M, Herbst RS, Boshoff C. Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med. 2021;27(8):1345\u201356. https:\/\/doi.org\/10.1038\/s41591-021-01450-2.","journal-title":"Nat Med"},{"key":"3817_CR9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1146\/annurev-pathol-012414-040438","volume":"10","author":"SR Stowell","year":"2015","unstructured":"Stowell SR, Ju T, Cummings RD. Protein glycosylation in cancer. Annu Rev Pathol. 2015;10:473\u2013510. https:\/\/doi.org\/10.1146\/annurev-pathol-012414-040438.","journal-title":"Annu Rev Pathol"},{"issue":"8","key":"3817_CR10","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41569-024-00998-z","volume":"21","author":"JC Chatham","year":"2024","unstructured":"Chatham JC, Patel RP. Protein glycosylation in cardiovascular health and disease. Nat Rev Cardiol. 2024;21(8):525\u201344. https:\/\/doi.org\/10.1038\/s41569-024-00998-z.","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"3817_CR11","doi-asserted-by":"publisher","first-page":"R229","DOI":"10.1016\/j.cub.2019.01.003","volume":"29","author":"J Eichler","year":"2019","unstructured":"Eichler J. Protein glycosylation. Curr Biol. 2019;29(7):R229\u201331. https:\/\/doi.org\/10.1016\/j.cub.2019.01.003.","journal-title":"Curr Biol"},{"issue":"6","key":"3817_CR12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41581-019-0129-4","volume":"15","author":"C Reily","year":"2019","unstructured":"Reily C, Stewart TJ, Renfrow MB, et al. Glycosylation in health and disease. Nat Rev Nephrol. 2019;15(6):346\u201366. https:\/\/doi.org\/10.1038\/s41581-019-0129-4.","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"3817_CR13","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1042\/bst20170483","volume":"46","author":"JM Burchell","year":"2018","unstructured":"Burchell JM, Beatson R, Graham R, et al. O-linked mucin-type glycosylation in breast cancer. Biochem Soc Trans. 2018;46(4):779\u201388. https:\/\/doi.org\/10.1042\/bst20170483.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"3817_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/bf01049675","volume":"13","author":"EF Hounsell","year":"1996","unstructured":"Hounsell EF, Davies MJ, Renouf DV. O-linked protein glycosylation structure and function. Glycoconj J. 1996;13(1):19\u201326. https:\/\/doi.org\/10.1007\/bf01049675.","journal-title":"Glycoconj J"},{"issue":"3","key":"3817_CR15","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.apsb.2023.10.014","volume":"14","author":"Y Lin","year":"2024","unstructured":"Lin Y, Lubman DM. The role of N-glycosylation in cancer. Acta Pharm Sin B. 2024;14(3):1098\u2013110. https:\/\/doi.org\/10.1016\/j.apsb.2023.10.014.","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"3817_CR16","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.sbi.2011.08.005","volume":"21","author":"F Schwarz","year":"2011","unstructured":"Schwarz F, Aebi M. Mechanisms and principles of N-linked protein glycosylation. Curr Opin Struct Biol. 2011;21(5):576\u201382. https:\/\/doi.org\/10.1016\/j.sbi.2011.08.005.","journal-title":"Curr Opin Struct Biol"},{"issue":"7","key":"3817_CR17","doi-asserted-by":"publisher","first-page":"e2411740","DOI":"10.1002\/advs.202411740","volume":"12","author":"N Xiong","year":"2025","unstructured":"Xiong N, Du Y, Huang C, et al. N-glycosylation Modification of CTSD Affects Liver Metastases in Colorectal Cancer. Adv Sci (Weinh). 2025;12(7):e2411740. https:\/\/doi.org\/10.1002\/advs.202411740.","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"3817_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s13238-020-00741-7","volume":"12","author":"J Zhang","year":"2021","unstructured":"Zhang J, Ten Dijke P, Wuhrer M, et al. Role of glycosylation in TGF-\u03b2 signaling and epithelial-to-mesenchymal transition in cancer. Protein Cell. 2021;12(2):89\u2013106. https:\/\/doi.org\/10.1007\/s13238-020-00741-7.","journal-title":"Protein Cell"},{"issue":"1","key":"3817_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/0113892029277397231228062412","volume":"25","author":"M Li","year":"2024","unstructured":"Li M, Deng X, Zhou D, et al. A Novel Methylation-based Model for Prognostic Prediction in Lung Adenocarcinoma. Curr Genomics. 2024;25(1):26\u201340. https:\/\/doi.org\/10.2174\/0113892029277397231228062412.","journal-title":"Curr Genomics"},{"issue":"1","key":"3817_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/0113892029298721240627095839","volume":"26","author":"Q Ren","year":"2025","unstructured":"Ren Q, Ma H, Wang L, et al. Gene-knockdown Methods for Silencing Nuclear-localized Insulin Receptors in Lung Adenocarcinoma Cells: A Bioinformatics Approach. Curr Genomics. 2025;26(1):24\u201335. https:\/\/doi.org\/10.2174\/0113892029298721240627095839.","journal-title":"Curr Genomics"},{"issue":"9","key":"3817_CR21","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3982","volume":"15","author":"SS Pinho","year":"2015","unstructured":"Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer. 2015;15(9):540\u201355. https:\/\/doi.org\/10.1038\/nrc3982.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"3817_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2174\/0109298665254683231122065717","volume":"31","author":"Z Qin","year":"2024","unstructured":"Qin Z, Xu Y. Dexmedetomidine Alleviates Brain Ischemia\/Reperfusion Injury by Regulating Metastasis-associated Lung Adenocarcinoma Transcript 1\/MicroRNA-140-5p\/ Nuclear Factor Erythroid-derived 2-like 2 Axis. Protein Pept Lett. 2024;31(2):116\u201327. https:\/\/doi.org\/10.2174\/0109298665254683231122065717.","journal-title":"Protein Pept Lett"},{"issue":"16","key":"3817_CR23","doi-asserted-by":"publisher","first-page":"5982","DOI":"10.1021\/bi047328f","volume":"44","author":"T Shibatani","year":"2005","unstructured":"Shibatani T, David LL, McCormack AL, et al. Proteomic analysis of mammalian oligosaccharyltransferase reveals multiple subcomplexes that contain Sect.\u00a061, TRAP, and two potential new subunits. Biochemistry. 2005;44(16):5982\u201392. https:\/\/doi.org\/10.1021\/bi047328f.","journal-title":"Biochemistry"},{"issue":"5","key":"3817_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.kjms.2014.01.003","volume":"30","author":"CM Chen","year":"2014","unstructured":"Chen CM, Tseng CN, Cho JJ, et al. Heat shock induces expression of OSTC\/DC2, a novel subunit of oligosaccharyltransferase, in vitro and in vivo. Kaohsiung J Med Sci. 2014;30(5):219\u201323. https:\/\/doi.org\/10.1016\/j.kjms.2014.01.003.","journal-title":"Kaohsiung J Med Sci"},{"issue":"11","key":"3817_CR25","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1083\/jcb.201702159","volume":"216","author":"S Shrimal","year":"2017","unstructured":"Shrimal S, Cherepanova NA, Gilmore R. DC2 and KCP2 mediate the interaction between the oligosaccharyltransferase and the ER translocon. J Cell Biol. 2017;216(11):3625\u201338. https:\/\/doi.org\/10.1083\/jcb.201702159.","journal-title":"J Cell Biol"},{"issue":"6385","key":"3817_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1126\/science.aar7899","volume":"360","author":"K Braunger","year":"2018","unstructured":"Braunger K, Pfeffer S, Shrimal S, et al. Structural basis for coupling protein transport and N-glycosylation at the mammalian endoplasmic reticulum. Science. 2018;360(6385):215\u20139. https:\/\/doi.org\/10.1126\/science.aar7899.","journal-title":"Science"},{"key":"3817_CR27","doi-asserted-by":"publisher","unstructured":"Mohanty S, Chaudhary BP, Zoetewey D. Structural Insight into the Mechanism of N-Linked Glycosylation by Oligosaccharyltransferase. Biomolecules. 2020;10(4). https:\/\/doi.org\/10.3390\/biom10040624.","DOI":"10.3390\/biom10040624"},{"issue":"11","key":"3817_CR28","doi-asserted-by":"publisher","first-page":"103271","DOI":"10.1016\/j.isci.2021.103271","volume":"24","author":"S Xie","year":"2021","unstructured":"Xie S, Jiang X, Qin R, et al. miR-1307 promotes hepatocarcinogenesis by CALR-OSTC-endoplasmic reticulum protein folding pathway. iScience. 2021;24(11):103271. https:\/\/doi.org\/10.1016\/j.isci.2021.103271.","journal-title":"iScience"},{"issue":"36","key":"3817_CR29","doi-asserted-by":"publisher","first-page":"31080","DOI":"10.1074\/jbc.M111.249748","volume":"286","author":"CM Wilson","year":"2011","unstructured":"Wilson CM, Magnaudeix A, Yardin C, et al. DC2 and keratinocyte-associated protein 2 (KCP2), subunits of the oligosaccharyltransferase complex, are regulators of the gamma-secretase-directed processing of amyloid precursor protein (APP). J Biol Chem. 2011;286(36):31080\u201391. https:\/\/doi.org\/10.1074\/jbc.M111.249748.","journal-title":"J Biol Chem"},{"key":"3817_CR30","doi-asserted-by":"publisher","first-page":"1457691","DOI":"10.3389\/fimmu.2024.1457691","volume":"15","author":"J Li","year":"2024","unstructured":"Li J, Chen M, Tong M, et al. TUBA1C orchestrates the immunosuppressive tumor microenvironment and resistance to immune checkpoint blockade in clear cell renal cell carcinoma. Front Immunol. 2024;15:1457691. https:\/\/doi.org\/10.3389\/fimmu.2024.1457691.","journal-title":"Front Immunol"},{"key":"3817_CR31","doi-asserted-by":"publisher","first-page":"1475235","DOI":"10.3389\/fimmu.2024.1475235","volume":"15","author":"L Cao","year":"2024","unstructured":"Cao L, Lu X, Wang X, et al. From single-cell to spatial transcriptomics: decoding the glioma stem cell niche and its clinical implications. Front Immunol. 2024;15:1475235. https:\/\/doi.org\/10.3389\/fimmu.2024.1475235.","journal-title":"Front Immunol"},{"issue":"1","key":"3817_CR32","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12935-021-01849-4","volume":"21","author":"T Bian","year":"2021","unstructured":"Bian T, Zheng M, Jiang D, et al. Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma. Cancer Cell Int. 2021;21(1):144. https:\/\/doi.org\/10.1186\/s12935-021-01849-4.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"3817_CR33","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1186\/s12885-023-11209-2","volume":"23","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Zhu C, Huang H, et al. TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle. BMC Cancer. 2023;23(1):716. https:\/\/doi.org\/10.1186\/s12885-023-11209-2.","journal-title":"BMC Cancer"},{"key":"3817_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fonc.2020.00049","volume":"10","author":"MAH Albahde","year":"2020","unstructured":"Albahde MAH, Zhang P, Zhang Q, et al. Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma via Regulating the Cell Cycle. Front Oncol. 2020;10:49. https:\/\/doi.org\/10.3389\/fonc.2020.00049.","journal-title":"Front Oncol"},{"issue":"11","key":"3817_CR35","doi-asserted-by":"publisher","first-page":"e0263710","DOI":"10.1371\/journal.pone.0263710","volume":"18","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Wang W, Li J, et al. Elevated expression of TUBA1C in breast cancer predicts poor prognosis. PLoS ONE. 2023;18(11):e0263710. https:\/\/doi.org\/10.1371\/journal.pone.0263710.","journal-title":"PLoS ONE"},{"issue":"1","key":"3817_CR36","doi-asserted-by":"publisher","first-page":"4478","DOI":"10.1038\/s41598-024-51973-0","volume":"14","author":"YF Sun","year":"2024","unstructured":"Sun YF, Zhang LC, Niu RZ, et al. Predictive potentials of glycosylation-related genes in glioma prognosis and their correlation with immune infiltration. Sci Rep. 2024;14(1):4478. https:\/\/doi.org\/10.1038\/s41598-024-51973-0.","journal-title":"Sci Rep"},{"issue":"24","key":"3817_CR37","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1097\/cm9.0000000000003442","volume":"137","author":"Y Wu","year":"2024","unstructured":"Wu Y, He S, Cao M, et al. Comparative analysis of cancer statistics in China and the United States in 2024. Chin Med J (Engl). 2024;137(24):3093\u2013100. https:\/\/doi.org\/10.1097\/cm9.0000000000003442.","journal-title":"Chin Med J (Engl)"},{"issue":"7689","key":"3817_CR38","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446\u201354. https:\/\/doi.org\/10.1038\/nature25183.","journal-title":"Nature"},{"issue":"7","key":"3817_CR39","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jamaoncol.2016.0333","volume":"2","author":"Z Piotrowska","year":"2016","unstructured":"Piotrowska Z, Sequist LV. Treatment of EGFR-Mutant Lung Cancers After Progression in Patients Receiving First-Line EGFR Tyrosine Kinase Inhibitors: A Review. JAMA Oncol. 2016;2(7):948\u201354. https:\/\/doi.org\/10.1001\/jamaoncol.2016.0333.","journal-title":"JAMA Oncol"},{"issue":"3","key":"3817_CR40","doi-asserted-by":"publisher","first-page":"152364","DOI":"10.1016\/j.seminoncol.2025.152364","volume":"52","author":"EM Tegaw","year":"2025","unstructured":"Tegaw EM, Asfaw BB. Explainable machine learning and feature interpretation to predict survival outcomes in the treatment of lung cancer. Semin Oncol. 2025;52(3):152364. https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152364.","journal-title":"Semin Oncol"},{"issue":"5","key":"3817_CR41","doi-asserted-by":"publisher","first-page":"192","DOI":"10.14715\/cmb\/2022.68.5.26","volume":"68","author":"R Wen","year":"2022","unstructured":"Wen R, Lin H, Li X, et al. The Regulatory Mechanism of EpCAM N-Glycosylation-Mediated MAPK and PI3K\/Akt Pathways on Epithelial-Mesenchymal Transition in Breast Cancer Cells. Cell Mol Biol (Noisy-le-grand). 2022;68(5):192\u2013201. https:\/\/doi.org\/10.14715\/cmb\/2022.68.5.26.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"3817_CR42","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3389\/fendo.2018.00602","volume":"9","author":"N Very","year":"2018","unstructured":"Very N, Vercoutter-Edouart AS, Lefebvre T, et al. Cross-Dysregulation of O-GlcNAcylation and PI3K\/AKT\/mTOR Axis in Human Chronic Diseases. Front Endocrinol (Lausanne). 2018;9:602. https:\/\/doi.org\/10.3389\/fendo.2018.00602.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"3817_CR43","doi-asserted-by":"publisher","first-page":"110582","DOI":"10.1016\/j.jbc.2025.110582","volume":"301","author":"AJ Navarro-Traxler","year":"2025","unstructured":"Navarro-Traxler AJ, Ghisolfi L, Lien EC, et al. The glycosyltransferase ALG3 is an AKT substrate that regulates protein N-glycosylation. J Biol Chem. 2025;301(9):110582. https:\/\/doi.org\/10.1016\/j.jbc.2025.110582.","journal-title":"J Biol Chem"},{"issue":"16","key":"3817_CR44","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1016\/j.molcel.2023.07.016","volume":"83","author":"P Latorre-Muro","year":"2023","unstructured":"Latorre-Muro P, Puigserver P. A sweet way to regulate cellular growth: OGT and mTOR join forces. Mol Cell. 2023;83(16):2832\u20133. https:\/\/doi.org\/10.1016\/j.molcel.2023.07.016.","journal-title":"Mol Cell"},{"issue":"1","key":"3817_CR45","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1038\/s41467-022-30696-8","volume":"13","author":"K Kim","year":"2022","unstructured":"Kim K, Yoo HC, Kim BG, et al. O-GlcNAc modification of leucyl-tRNA synthetase 1 integrates leucine and glucose availability to regulate mTORC1 and the metabolic fate of leucine. Nat Commun. 2022;13(1):2904. https:\/\/doi.org\/10.1038\/s41467-022-30696-8.","journal-title":"Nat Commun"},{"key":"3817_CR46","doi-asserted-by":"publisher","unstructured":"Paneque A, Fortus H, Zheng J, et al. The Hexosamine Biosynthesis Pathway: Regulation and Function. Genes (Basel). 2023;14(4). https:\/\/doi.org\/10.3390\/genes14040933.","DOI":"10.3390\/genes14040933"},{"issue":"10","key":"3817_CR47","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.32604\/or.2025.066805","volume":"33","author":"X Huang","year":"2025","unstructured":"Huang X, Gu R, Li Z, et al. Igniting Cold Tumors: Multi-Omics-Driven Strategies to Overcome Immune Evasion and Restore Immune Surveillance. Oncol Res. 2025;33(10):2857\u2013902. https:\/\/doi.org\/10.32604\/or.2025.066805.","journal-title":"Oncol Res"},{"issue":"1","key":"3817_CR48","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","volume":"10","author":"M Tufail","year":"2025","unstructured":"Tufail M, Jiang CH, Li N. Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Signal Transduct Target Ther. 2025;10(1):227. https:\/\/doi.org\/10.1038\/s41392-025-02280-1.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"3817_CR49","doi-asserted-by":"publisher","first-page":"189312","DOI":"10.1016\/j.bbcan.2025.189312","volume":"1880","author":"M Cui","year":"2025","unstructured":"Cui M, Zhou M, Zhou L, et al. Tertiary lymphoid structures achieve \u2018cold\u2019 to \u2018hot\u2019 transition by remodeling the cold tumor microenvironment. Biochim Biophys Acta Rev Cancer. 2025;1880(3):189312. https:\/\/doi.org\/10.1016\/j.bbcan.2025.189312.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3817_CR50","doi-asserted-by":"publisher","first-page":"117194","DOI":"10.1016\/j.bcp.2025.117194","volume":"241","author":"X Kong","year":"2025","unstructured":"Kong X, Ou S, Wei Z, et al. Transforming the cold tumors to hot tumors: strategies for immune activation. Biochem Pharmacol. 2025;241:117194. https:\/\/doi.org\/10.1016\/j.bcp.2025.117194.","journal-title":"Biochem Pharmacol"},{"key":"3817_CR51","doi-asserted-by":"publisher","first-page":"1770711","DOI":"10.3389\/fimmu.2026.1770711","volume":"17","author":"Y Wang","year":"2026","unstructured":"Wang Y, Zhang Y, Li Y, et al. The value of Protein Phosphatase Methylesterase 1 in diagnosis, prognosis and immunoregulation: from pan-cancer analysis to breast cancer verification. Front Immunol. 2026;17:1770711. https:\/\/doi.org\/10.3389\/fimmu.2026.1770711.","journal-title":"Front Immunol"},{"issue":"1","key":"3817_CR52","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41467-020-16164-1","volume":"11","author":"N Kim","year":"2020","unstructured":"Kim N, Kim HK, Lee K, et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat Commun. 2020;11(1):2285. https:\/\/doi.org\/10.1038\/s41467-020-16164-1.","journal-title":"Nat Commun"},{"issue":"1","key":"3817_CR53","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13045-024-01559-0","volume":"17","author":"B Toledo","year":"2024","unstructured":"Toledo B, Zhu Chen L, Paniagua-Sancho M, et al. Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy. J Hematol Oncol. 2024;17(1):44. https:\/\/doi.org\/10.1186\/s13045-024-01559-0.","journal-title":"J Hematol Oncol"},{"key":"3817_CR54","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.2147\/bctt.S553681","volume":"17","author":"Y Gou","year":"2025","unstructured":"Gou Y, Li Y, Wang Y, et al. Integrated Pan-Cancer Profiling and Breast Cancer Validation Identify BEND3 as a Potential Prognostic and Immune Biomarker. Breast Cancer (Dove Med Press). 2025;17:1439\u201361. https:\/\/doi.org\/10.2147\/bctt.S553681.","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"3817_CR55","doi-asserted-by":"publisher","first-page":"1667589","DOI":"10.3389\/fonc.2025.1667589","volume":"15","author":"J Wang","year":"2025","unstructured":"Wang J, Wang Y, Ma H, et al. CLIC6\u2019s role in cancer: from broad analysis to breast cancer validation. Front Oncol. 2025;15:1667589. https:\/\/doi.org\/10.3389\/fonc.2025.1667589.","journal-title":"Front Oncol"},{"key":"3817_CR56","doi-asserted-by":"publisher","first-page":"1638102","DOI":"10.3389\/fimmu.2025.1638102","volume":"16","author":"OV Kovaleva","year":"2025","unstructured":"Kovaleva OV, Rashidova MA, Sinyov VV, et al. M1 macrophages - unexpected contribution to tumor progression. Front Immunol. 2025;16:1638102. https:\/\/doi.org\/10.3389\/fimmu.2025.1638102.","journal-title":"Front Immunol"},{"issue":"10","key":"3817_CR57","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138. https:\/\/doi.org\/10.1038\/s41591-018-0136-1.","journal-title":"Nat Med"},{"issue":"1","key":"3817_CR58","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12967-024-05186-8","volume":"22","author":"K Zheng","year":"2024","unstructured":"Zheng K, Hai Y, Chen H, et al. Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model. J Transl Med. 2024;22(1):365. https:\/\/doi.org\/10.1186\/s12967-024-05186-8.","journal-title":"J Transl Med"},{"issue":"1","key":"3817_CR59","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13046-025-03394-8","volume":"44","author":"S Imani","year":"2025","unstructured":"Imani S, Farghadani R, Roozitalab G, et al. Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy. J Exp Clin Cancer Res. 2025;44(1):131. https:\/\/doi.org\/10.1186\/s13046-025-03394-8.","journal-title":"J Exp Clin Cancer Res"},{"key":"3817_CR60","doi-asserted-by":"publisher","unstructured":"Hayashi H, Chamoto K, Hatae R, et al. Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade. J Clin Invest. 2024;134(7). https:\/\/doi.org\/10.1172\/jci168318.","DOI":"10.1172\/jci168318"},{"issue":"1","key":"3817_CR61","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13046-021-01872-3","volume":"40","author":"A Relecom","year":"2021","unstructured":"Relecom A, Merhi M, Inchakalody V, et al. Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity. J Exp Clin Cancer Res. 2021;40(1):74. https:\/\/doi.org\/10.1186\/s13046-021-01872-3.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1Supplement","key":"3817_CR62","doi-asserted-by":"publisher","first-page":"11634204","DOI":"10.4049\/jimmunol.212.supp.1163.4204","volume":"212","author":"T LIU","year":"2024","unstructured":"LIU T. B7H3 (CD276) regulation of myeloid cell differentiation in pulmonary fibrosis. J Immunol. 2024;212(1Supplement):11634204\u201311634204. https:\/\/doi.org\/10.4049\/jimmunol.212.supp.1163.4204.","journal-title":"J Immunol"},{"key":"3817_CR63","doi-asserted-by":"publisher","unstructured":"Liu L, Yao Z, Liu Y, et al. A Pan-Cancer Analysis of the Oncogenic Role of CD276 in Human Tumors. Genes (Basel). 2024;15(12). https:\/\/doi.org\/10.3390\/genes15121527.","DOI":"10.3390\/genes15121527"},{"issue":"2","key":"3817_CR64","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00280-024-04668-2","volume":"94","author":"X Xu","year":"2024","unstructured":"Xu X, Liu Y, Gong Q, et al. PARP1 promotes EGFR-TKI drug-resistance via PI3K\/AKT pathway in non-small-cell lung cancer. Cancer Chemother Pharmacol. 2024;94(2):209\u201321. https:\/\/doi.org\/10.1007\/s00280-024-04668-2.","journal-title":"Cancer Chemother Pharmacol"},{"key":"3817_CR65","doi-asserted-by":"publisher","unstructured":"Holz C, Lange S, Sekora A, et al. Combined BCL-2 and PI3K\/AKT Pathway Inhibition in KMT2A-Rearranged Acute B-Lymphoblastic Leukemia Cells. Int J Mol Sci. 2023;24(2). https:\/\/doi.org\/10.3390\/ijms24021359.","DOI":"10.3390\/ijms24021359"},{"issue":"5","key":"3817_CR66","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1007\/s12033-025-01494-6","volume":"68","author":"D Chen","year":"2026","unstructured":"Chen D, Nie Y, Shi L, et al. GALNT18-Mediated O-Glycosylation Promotes Development of Nonalcoholic Steatohepatitis-Associated Hepatocellular Carcinoma Through Activation of EGR1\/TGF-\u03b21\/Smad Signaling. Mol Biotechnol. 2026;68(5):2264\u201384. https:\/\/doi.org\/10.1007\/s12033-025-01494-6.","journal-title":"Mol Biotechnol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03817-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03817-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03817-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:03:40Z","timestamp":1788800620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-026-03817-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3817"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03817-w","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Publicly available LUAD sample data (TCGA, GEO, BioStudies) were utilized in this study under ethical approvals from the respective database hosting institutions, in accordance with the Declaration of Helsinki and relevant ethical guidelines. Cell lines (BEAS 2B, A549, and H1299) were obtained from Procell System (Wuhan, China), with authorization for use granted by that institution. The experimental protocol was approved by the Ethics Committee of Bengbu Medical University, and all procedures were performed in compliance with applicable guidelines and regulations.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"346"}}